65,437 trials
Lung Adenocarcinoma · Lung Adenosquamous Carcinoma · Malignant Pericardial Effusion
Primary: 18 Weeks Progression Free Survival (PFS) Rate — 52; 69 percentage of participants
Skin Laxity · Wrinkles
Primary: Improvement in Overall Lifting and Tightening of the Skin — 67 percentage of participants
Children · Obstructive Uropathy · Acute Renal Failure
Primary: Period to Return to Normal Creatinine — 2.22; 2.18 days
Chest Pain · Cardiovascular Diseases · Angina Pectoris
Primary: Change in Clinicians' Treatment Decision After Age/Sex/Gene Expression Score — 38; 1; 1; 0 number of subjects — p=<0.001
Medication Adherence · Bipolar Disorder
Primary: Treatment Non-adherence Percentage as Measured by the Tablet Routines Questionnaire (TRQ) — 16.11; 13.88 Percentage of doses
Type II Hyperlipidemia
Primary: Percent Change in HDL-C From Baseline — 3.2; 84.2; 122.1; 160.6 percent change from baseline
Post Operative Pain
Primary: Morphine Consumption — 38.4; 38.6; 42.6 mg
Obesity · Osteoarthritis
Primary: Peak Vertical Force on Affected Limb — 9.5; 8.5; 8.8; 7.5 N/kg
Childhood Obesity
Primary: Change in Children´s Consumption of Foods From Baseline to 3 Months by Intervention Assignment — -0.8; -5.5; 0.1; -1.9 servings/week — p=<0.05
Atherosclerosis · Cardiovascular Disease · Inflammation
Primary: Change in Systemic Glucose Disposal- Glucose Infusion Rates — 1; 6 percent change from baseline — p=<0.05
Migraine
Primary: Proportion of Subjects With Allodynia During a Migraine Attack — 15 participants
Erythema · Edema · Papules White
Primary: Total Number of Adverse Events Experienced by Participants Between Day 0 and Day 14 After Receiving the Prima-Temp Temparature Patch — 1 Adverse event
Obstructive Sleep Apnea
Primary: Cost — 4621; 4057 dollars
Multiple Myeloma
Primary: International Myeloma Working Group (IMWG) Response Criteria — 8; 4; 7; 19 participants
Healthy
Primary: Metabolic Rate During Barefoot and Shod Running — 57.8; 57.5 kilojoules per minute